• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A simplified Sanger sequencing method for full genome sequencing of multiple subtypes of human influenza A viruses

tetano

Editor, Senior Moderator
J Clin Virol. 2015 Jul;68:43-8. doi: 10.1016/j.jcv.2015.04.019. Epub 2015 Apr 28.
[h=1]A simplified Sanger sequencing method for full genome sequencing of multiple subtypes of human influenza A viruses.[/h] Deng YM[SUP]1[/SUP], Spirason N[SUP]2[/SUP], Iannello P[SUP]2[/SUP], Jelley L[SUP]2[/SUP], Lau H[SUP]2[/SUP], Barr IG[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Full genome sequencing of influenza A viruses (IAV), including those that arise from annual influenza epidemics, is undertaken to determine if reassorting has occurred or if other pathogenic traits are present. Traditionally IAV sequencing has been biased toward the major surface glycoproteins haemagglutinin and neuraminidase, while the internal genes are often ignored. Despite the development of next generation sequencing (NGS), many laboratories are still reliant on conventional Sanger sequencing to sequence IAV.
[h=4]OBJECTIVES:[/h] To develop a minimal and robust set of primers for Sanger sequencing of the full genome of IAV currently circulating in humans.
[h=4]STUDY DESIGN:[/h] A set of 13 primer pairs was designed that enabled amplification of the six internal genes of multiple human IAV subtypes including the recent avian influenza A(H7N9) virus from China. Specific primers were designed to amplify the HA and NA genes of each IAV subtype of interest. Each of the primers also incorporated a binding site at its 5'-end for either a forward or reverse M13 primer, such that only two M13 primers were required for all subsequent sequencing reactions.
[h=4]RESULTS:[/h] This minimal set of primers was suitable for sequencing the six internal genes of all currently circulating human seasonal influenza A subtypes as well as the avian A(H7N9) viruses that have infected humans in China.
[h=4]CONCLUSIONS:[/h] This streamlined Sanger sequencing protocol could be used to generate full genome sequence data more rapidly and easily than existing influenza genome sequencing protocols.
Copyright ? 2015 The Authors. Published by Elsevier B.V. All rights reserved.


[h=4]KEYWORDS:[/h] Full genome sequencing; Influenza A virus; Sanger sequencing

PMID: 26071334 [PubMed - in process] Free full text
 
Back
Top Bottom